Stephen Liu, MD | Authors


Newly Diagnosed ALK+ Non–Small Cell Lung Cancer

August 21, 2020

Medstar Georgetown University Hospital’s Dr Stephen Liu shares impressions on the way a 57-year-old man with ALK-positive metastatic non–small cell lung cancer was managed, highlighting the rationale for using a second-generation ALK inhibitor as treatment.